BREAKINGON
rape search result
Scientists Debate the Future of 'Mirror Life' Research: Risk vs Reward

Scientists Debate the Future of 'Mirror Life' Research: Risk vs Reward

SCIENCE - 9/15/2025

In Manchester, scientists are divided over the implications of 'mirror life' research, which could lead to synthetic cells with mirror-image molecules. While some see potential benefits, others warn of significant health and environmental risks.

From Gridiron to Life-Saving Innovation: Jim Czirr's Journey

From Gridiron to Life-Saving Innovation: Jim Czirr's Journey

SPORTS - 9/6/2025

Discover the inspiring journey of Jim Czirr, former Michigan football star, as he transitions from battling legends on the field to fighting cancer through groundbreaking drug development.

Emma Raducanu and Carlos Alcaraz’s Doubles Dream Ends in Disappointment at US Open

Emma Raducanu and Carlos Alcaraz’s Doubles Dream Ends in Disappointment at US Open

SPORTS - 8/20/2025

In a highly anticipated match, Emma Raducanu and Carlos Alcaraz's doubles partnership was swiftly defeated by the top-seeded duo of Jessica Pegula and Jack Draper, who are now on a winning streak in the US Open.

Man Convicted of Rape After Faking His Own Death: Shocking Utah Case

Man Convicted of Rape After Faking His Own Death: Shocking Utah Case

POLITICS - 8/14/2025

In a dramatic turn of events, Nicholas Alahverdian, who faked his death to escape sexual assault charges, was convicted of rape in Utah. The survivor's brave testimony led to justice. Sentencing is set for October 20.

US Government Cancels $500 Million in mRNA Vaccine Contracts: What's Next?

US Government Cancels $500 Million in mRNA Vaccine Contracts: What's Next?

HEALTH - 8/13/2025

In a surprising move, the US Department of Health has canceled contracts worth $500 million related to mRNA vaccine research, sparking concerns about future pandemic preparedness and the direction of vaccine technology.

FDA Clears Path for Sarepta's Duchenne Muscular Dystrophy Gene Therapy

FDA Clears Path for Sarepta's Duchenne Muscular Dystrophy Gene Therapy

HEALTH - 7/29/2025

In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.

Hope and Heartbreak: Families Face Tough Choices Amid Gene Therapy Controversy

Hope and Heartbreak: Families Face Tough Choices Amid Gene Therapy Controversy

HEALTH - 7/26/2025

As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.

Sarepta Therapeutics Faces Hurdles in Reviving Controversial Gene Therapy

Sarepta Therapeutics Faces Hurdles in Reviving Controversial Gene Therapy

HEALTH - 7/22/2025

Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.

Sarepta Therapeutics Faces Scrutiny After Another Gene Therapy-Related Death

Sarepta Therapeutics Faces Scrutiny After Another Gene Therapy-Related Death

HEALTH - 7/19/2025

Sarepta Therapeutics is under fire as another patient succumbs to acute liver failure linked to its gene therapy trial for muscular dystrophy, adding to the recent deaths of two teenage boys.

US Deports 'Criminal Illegal Aliens' to Eswatini: A Controversial Move

US Deports 'Criminal Illegal Aliens' to Eswatini: A Controversial Move

POLITICS - 7/16/2025

In a controversial move, the US has deported five convicted criminals to Eswatini, labeled as 'depraved monsters' by officials. This unprecedented action raises questions about international immigration policies and the fate of deportees.

Breakingon.com is an independent news platform that delivers the latest news, trends, and analyses quickly and objectively. We gather and present the most important developments from around the world and local sources with accuracy and reliability. Our goal is to provide our readers with factual, unbiased, and comprehensive news content, making information easily accessible. Stay informed with us!
© Copyright 2025 BreakingOn. All rights reserved.